JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

Home・Akcijų sąrašas・Boston Scientific Corp.

Boston Scientific Corp.

Uždarymo kaina

SektoriusSveikatos priežiūra

55.97 -1.62

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

55.87

Max

56.99

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-83M 672M
Pardavimai	-83M 5.2B
P/E Sektoriaus vid.	25.084 67.147
Pelnas, tenkantis vienai akcijai	0.8
Pelno marža	12.713
Darbuotojai	59,000
EBITDA	116M 1.1B

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+56.76% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-07-29

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-1.5B 89B
Ankstesnė atidarymo kaina	57.59
Ankstesnė uždarymo kaina	55.97

Naujienos nuotaikos

By Acuity

51%

49%

281 / 347 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

102.95 / 104.93 Palaikymas ir pasipriešinimas

Boston Scientific Corp. Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-04-22 11:22; UTC

Uždarbis

Boston Scientific 1Q Net Grows Sharply, Company Cuts 2026 Adjusted EPS View

2026-02-04 16:14; UTC

Uždarbis

Pagrindinės rinkos jėgos

Boston Scientific Plunges on Disappointing 1Q Outlook Despite 4Q Earnings Beat

2026-02-04 12:13; UTC

Uždarbis

Boston Scientific Sees More Growth after Earnings, Sales Rise

2026-04-22 11:07; UTC

Uždarbis

Boston Scientific 1Q Net Grows Sharply, Company Cuts 2026 Adj EPS View

2026-04-22 10:32; UTC

Uždarbis

Boston Scientific Now Sees 2026 Reported Sales Up 7%-8.5%, Organic Sales Up 6.5%-8% >BSX

2026-04-22 10:31; UTC

Uždarbis

Boston Scientific Sees 2Q Reported Sales Up 5.5%-7.5%, Organic Sales Up 5%-7% >BSX

2026-04-22 10:30; UTC

Uždarbis

Boston Scientific 1Q Organic Sales Up 9.4% >BSX

2026-04-22 10:30; UTC

Uždarbis

Boston Scientific 1Q Adj EPS 80c >BSX

2026-04-22 10:30; UTC

Uždarbis

Boston Scientific 1Q EPS 90c >BSX

2026-04-22 10:30; UTC

Uždarbis

Boston Scientific 1Q Sales $5.2B >BSX

2026-04-22 10:30; UTC

Uždarbis

Boston Scientific Sees 2Q Adj EPS 82c-Adj EPS 84c >BSX

2026-04-22 10:30; UTC

Uždarbis

Boston Scientific Sees FY Adj EPS $3.34-Adj EPS $3.41 >BSX

2026-03-30 15:34; UTC

Rinkos pokalbiai

Boston Scientific Faces Some Slowing Growth Trends -- Market Talk

2026-02-04 21:41; UTC

Uždarbis

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

2026-02-04 19:38; UTC

Uždarbis

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

2026-02-04 17:32; UTC

Uždarbis

These Stocks Are Today's Movers: AMD, AbbVie, Eli Lilly, Boston Scientific, MP Materials, Super Micro, Silicon Labs, Uber, and More -- Barrons.com

2026-02-04 15:30; UTC

Uždarbis

Boston Scientific Earnings Beat Estimates. It's the Worst Stock in the S&P 500 Today. -- Barrons.com

2026-02-04 15:29; UTC

Uždarbis

These Stocks Are Today's Movers: AMD, Eli Lilly, AbbVie, Uber, Super Micro, Enphase, Boston Scientific, and More -- Barrons.com

2026-02-04 14:06; UTC

Uždarbis

Boston Scientific Profit, Sales Rise but Issues Soft Guidance -- Update

2026-02-04 13:58; UTC

Uždarbis

Boston Scientific Earnings Beat Expectations. Why the Stock Is Down Sharply. -- Barrons.com

2026-02-04 13:12; UTC

Uždarbis

Boston Scientific Earnings Beat Expectations. Why the Stock Is Down Sharply. -- Barrons.com

2026-02-04 11:32; UTC

Uždarbis

Boston Scientific Sees 2026 Sales Up 10.5%-11.5%, Organic Sales Up 10%-11% >BSX

2026-02-04 11:31; UTC

Uždarbis

Boston Scientific Sees 1Q Sales Up 10.5%-12%, Organic Sales Up 8.5%-10% >BSX

2026-02-04 11:30; UTC

Uždarbis

Boston Scientific 4Q Organic Sales Up 12.7% >BSX

2026-02-04 11:30; UTC

Uždarbis

Boston Scientific Sees 2026 Adj EPS $3.43-Adj EPS $3.49 >BSX

2026-02-04 11:30; UTC

Uždarbis

Boston Scientific Sees 1Q Adj EPS 78c-Adj EPS 80c >BSX

2026-02-04 11:30; UTC

Uždarbis

Boston Scientific 4Q Adj EPS 80c >BSX

2026-02-04 11:30; UTC

Uždarbis

Boston Scientific 4Q Sales $5.29B >BSX

2026-02-04 11:30; UTC

Uždarbis

Boston Scientific 4Q EPS 45c >BSX

2026-01-24 06:18; UTC

Įsigijimai, susijungimai, perėmimai

Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Boston Scientific Corp. Prognozė

Kainos tikslas

By TipRanks

56.76% į viršų

12 mėnesių prognozė

Vidutinis 89.12 USD 56.76%

Aukščiausias 118 USD

Žemiausias 71 USD

Remiantis 27 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Boston Scientific Corp. kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

27 ratings

Pirkti

Laikyti

Parduoti

Remiantis 27 analitikų, pateikusių Boston Scientific Corp. akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

102.95 / 104.93Palaikymas ir pasipriešinimas

All events are bullish.

Recent bearish events outweigh bullish events.

There are no events.

Rinkos nuotaikos

By Acuity

281 / 347 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Boston Scientific Corp.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.